Skip to content

Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study

Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03810599
Acronym
BECARES
Enrollment
870
Registered
2019-01-18
Start date
2013-09-09
Completion date
2029-02-01
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Cardiac rehabilitation adherence, Patient-reported outcomes, Post-traumatic growth, Anxiety, Depression, Adherence, Lifestyle, Self-reported health

Brief summary

An intervention study with longitudinal follow-up of patients with coronary artery disease undergoing early cardiac rehabilitation is designed.

Detailed description

The main objective of the study is to investigate patient-reported outcomes, their relation to clinical characteristics of the patients and the potential to predict health outcomes and adverse events in coronary artery disease patients participating in an early cardiac rehabilitation programme.

Interventions

OTHEREarly cardiac rehabilitation

This is an early cardiac rehabilitation programme starting 1-2 weeks after hospital discharge (Phase 2A rehabilitation). The programme provided by a multidisciplinary team includes individual counseling, educational sessions and discussion in groups, and exercise training sessions three days a week for five weeks. For additional analysis there will be a comparison group that did not receive the intervention for practical reasons.

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Pre-post comparison.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of coronary artery disease * \>=18 years of age * Has performed a negative exercise test (bike or treadmill) and thereby able to participate in exercise training.

Exclusion criteria

* Cognitive impairment * Unstable angina pectoris * Aortic stenosis * Left ventricular ejection fraction \<30% * Heart failure NYHA class III-IV * Serious arrhythmia in need of treatment * Being on the waiting list for percutaneous coronary intervention or coronary artery bypass grafting.

Design outcomes

Primary

MeasureTime frameDescription
Time to composite of total mortality, and hospitalization for heart failure and atherothrombotic disease (including non-fatal MI, unstable angina and stroke).Up to 10 yearsTime to combined endpoint from inclusion.

Secondary

MeasureTime frameDescription
Change in Self-reported healthImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe EuroQol 5-dimensions-5 level questionnaire (EQ-5D-5L) is an 5 item self-report-questionnaire assessing self-reported health. The respondent rates each item on a 5-point scale ranging from 1(indicating no problem) to 5 (indicating extreme problems). This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Change in self-reported global healthImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe VAS scale from the EQ-5D-5L assess global health. The scale goes from 0 to 100 were lower score indicates worse health.
Change in post traumatic growthImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe Posttraumatic Growth Inventory-Short Form (PTGI-SF) is a 10 item scale measuring post traumatic growth. The respondent rates each item on a 6-point scale ranging from 0 (I did not experience this change as a result of my crisis) to 5 (I experienced this change to a very great degree as a result of my crisis). The scale is scored by adding all the responses.Individual factors are scored by adding responses to items on each factor. Factors are indicated by the Roman numerals after each item.
Nicotine dependenceImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe Fagerström test
Change in anxiety and depressionImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe Hospital Anxiety and Depression Scale (HADS) is a fourteen item scale where seven of the items relate to anxiety and seven relate to depression. The respondent rates each item on a 4-point scale ranging from 0 (absence) to 3 (extreme presence). The total score is 42 (21 per subscale).
Change in physical and mental dimensions of healthImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe Short Form Health Survey (SF-12) include 12 items with 3 to 5 response levels. It generates two health indices: mental health and physical health. The score range between 0 and 100, with 100 representing the highest level of health
Change in health status following myocardial infarctionImmediately after the 5 week intervention, and at 9, 31, 57 and 109 weeksThe Myocardial Infarction Dimensional Assessment Scale (MIDAS) is a PRO measure developed and validated to specifically measure the health status of individuals who have suffered a myocardial infarction. It consist of 7 domains, and is a 35 item scale where respondents rate each item on a 5-point scale ranging from 1 (never) to 5 (always). The function of the MIDAS is to indicate the extent of ill health in each of the seven domains assessed, therefore each dimension is scored separately using a simple scoring methodology.

Countries

Norway

Contacts

PRINCIPAL_INVESTIGATORTone M Norekvål, PhD

Haukeland University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026